⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

April 9, 2024Neurology

A Preliminary Systematic Review and Meta-analysis of Randomized Control Trials of Rimegepant and Zavegepant for Acute Pain Relief from Migraine (P9-12.004)

Sakina Matcheswalla Kuldeep N. Yadav Rahul Jena Lakshmi Sai Deepak Reddy Velugoti Prince Kwabla Perkyi-Boateng Aleksei Budnik Zabeen Mahuwala

View Full Paper

Ask AI

Bookmark

Share

Abstract

Our aim was to compare the efficacy of Rimegepant and Zavegepant in relieving pain from migraine in acute settings.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Matcheswalla et al. (2024) studied this question.

synapsesocial.com/papers/68e6fcc5b6db643587677425 https://doi.org/10.1212/wnl.0000000000206425

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Systematic review and meta-analysis on the efficacy and safety of rimegepant for migraineMeta-Analysis · 2026 · 1 citations
2Efficacy and Safety of Zavegepant for the Acute Treatment of Migraine in Women: Results from 2 Randomized, Placebo-controlled Clinical Trials (P6-12.004)2024 · 1 citations
3Cost-effectiveness analysis of ubrogepant, rimegepant, and zavegepant for acute migraine treatment vs usual care.2025
4Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States2024 · 8 citations
5Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial2024 · 27 citations